You searched for "outcome"

2470 results found

Elevated risk of mood disorders after recurrent retinal detachment

This study was aimed to investigate the risk of mood disorders in patients who experienced retinal detachment (RD) by using the National Health Insurance Research Database in Taiwan. A total of 4129 participants diagnosed with RD and 16,516 non-RD individuals...

Balancing early and late surgical intervention for congenital nasolacrimal duct obstruction

This retrospective study investigated the incidence of anisometropia and amblyopia by age of congenital nasolacrimal duct obstruction (CNLDO) resolution. At Seattle children’s hospital, between 2007 and 2017, the outcomes of children with early versus late spontaneous resolution of CNLDO were...

Chandelier-assisted versus standard scleral buckling for rhegmatogenous retinal detachment repair. Systematic review and meta-analysis

Despite a significant global decline in standard scleral buckling (SSB) procedures for rhegmatogenous retinal detachment (RRD), it continues to hold its place as an essential treatment option, offering distinct advantages such as cost-effectiveness, preservation of the vitreous, improved final visual...

Haag-Streit Academy 2024 course schedule released – book your place now!

Haag-Streit Academy is pleased to launch it’s 2024 course schedule. The schedule features our popular CPD-accredited training and education events which include informative lectures and practical, hands-on workshops, delivered by industry experts.

Haag-Streit Academy celebrates 10 years of first class clinical CPD-accredited training

Haag-Streit UK is pleased to celebrate 10 years of providing high quality slit lamp, biometry and perimetry training. In 2014, the Haag-Streit Academy was born, with the launch of the first ‘Improving Outcomes’ biometry course.

Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system

Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...

Haag-Streit Academy announces course schedule for 2025

Haag-Streit Academy are pleased to announce their course schedule for 2025, which features eight slit lamp and biometry courses in prime locations across the UK. The courses offer attendees the vital skills and knowledge to utilise their slit lamp and...

RayOne EMV honoured with King’s Award for Enterprise

Rayner, the UK’s sole manufacturer of intraocular lenses (IOLs) and a global leader in cataract surgery solutions, has received the prestigious King’s Award for Enterprise 2025 in the Innovation category for its groundbreaking RayOne EMV lens. Launched in 2020 and...

Assessing the effectiveness of undergraduate ophthalmic assessments in the UK: A literature review

During 2008–2009, 300,000 patients presented to hospital emergency departments in the UK with eye conditions. This rose by nearly 200,000 over the next decade. As the population ages, the prevalence of eye disease increases [1,2]. However, the stake ophthalmology holds...

The role of spectral-domain OCT RNFL in revealing a pituitary adenoma with atypical visual fields

Pituitary adenomas classically cause bitemporal hemianopia by compressing the optic chiasm. However, in some cases, the pattern of visual field loss may be atypical and mimic homonymous hemianopia, depending on the direction and extent of tumour expansion. Spectral-domain optical coherence...

Scottish budget 2026–27: Optometry Scotland welcomes continued investment in community eyecare

Optometry Scotland (OS) welcomes the Scottish Budget 2026–27, which confirms continued investment in community optometry and reinforces its established role in delivering accessible eyecare across Scotland. The Budget confirms community eyecare funding of £144.5 million for 2026–27, representing a cash...

The role of inflammation in the pathophysiology of DMO

Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...